Early predictors of efficacy of biological therapy for psoriasis in children
https://doi.org/10.53529/2500-1175-2023-1-49-52
About the Authors
D. G. Kuptsova
National Medical Research Center for Children’s Health
Russian Federation
Russian Federation
119991, Moscow, Lomonosovsky prospect, 2, building 1
S. V. Petrichuk
National Medical Research Center for Children’s Health
Russian Federation
Russian Federation
119991, Moscow, Lomonosovsky prospect, 2, building 1
N. N. Murashkin
National Medical Research Center for Children’s Health
Russian Federation
Russian Federation
119991, Moscow, Lomonosovsky prospect, 2, building 1
T. V. Radigina
National Medical Research Center for Children’s Health
Russian Federation
Russian Federation
119991, Moscow, Lomonosovsky prospect, 2, building 1
O. V. Kurbatova
National Medical Research Center for Children’s Health
Russian Federation
Russian Federation
119991, Moscow, Lomonosovsky prospect, 2, building 1
References
1. Yamanaka K, Yamamoto O, Honda T. Pathophysiology of psoriasis: A review. The Journal of dermatology. 2021; 48 (6): 722–731. https://doi.org/10.1111/1346-8138.15913.
2. Schön MP. Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders. Frontiers in immunology. 2019; 10: 1764. https://doi.org/10.3389/fimmu.2019.01764.
3. Hu P, Wang M, Gao H, Zheng A, Li J, Mu D, Tong J. The Role of Helper T Cells in Psoriasis. Frontiers in immunology. 2021; 12: 788940. https://doi.org/10.3389/fimmu.2021.788940.
4. Zhong L, Luo N, Zhong X, Xu T, Hao, P. The immunoregulatory effects of natural products on psoriasis via its action on Th17 cells versus regulatory T-cells balance. International immunopharmacology. 2022; 110: 109032. https://doi.org/10.1016/j.intimp.2022.109032.
5. Kuptsova DG, Radygina TV, Murashkin NN, Petrichuk SV. Pokazateli kletochnogo immuniteta i kletki-supressory mieloidnogo proiskhozhdeniya u detej s psoriazom. Immunopathology, allergology, infectology. — 2020. — № 3. — S. 55–65. (In Russ.) https://doi.org/10.14427/jipai.2020.3.55.
6. Uttarkar S, Brembilla NC, Boehncke WH. Regulatorycells in the skin: Pathophysiologic role and potential targets for anti-inflammatory therapies. The Journal of allergy and clinical immunology. 2019; 143 (4): 1302–1310. https://doi.org/10.1016/j.jaci.2018.12.1011.
7. DeJesús-Gil C, Sans-de San Nicolàs L, García-Jiménez I, Ferran M, Pujol R M, Santamaria-Babí LF. Human CLA+ Memory T Cell and Cytokines in Psoriasis. Frontiers in medicine. 2021; 8: 731911. https://doi.org/10.3389/fmed.2021.731911.
8. Shibata M, Nanno K, Yoshimori D et al. Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more. Oncotarget. 2022; 13: 1273–1285. https://doi.org/10.18632/oncotarget.28303.
9. Ivanov RA, Murashkin NN. Vyzhivaemost’ biologicheskoj terapii u detej, stradayushchih psoriazom: kogortnoe issledovanie. Voprosy sovremennoj pediatrii. — 2021. — Т. 20. — № 5. — S. 451–458. (In Russ.) https://doi.org/10.15690/vsp.v20i5.2323.
10. Liau MM, Oon HH. Therapeutic drug monitoring of biologics in psoriasis. Biologics. 2019; 13: 127–132. Published 2019 Jul 5. https://doi.org/10.2147/BTT.S188286.
11. Yiu ZZN, Becher G, Kirby B, Laws P, Reynolds NJ, Smith CH, Warren R B, Griffiths CEM, & BADBIR Study Group. Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis. JAMA dermatology. 2022; 158 (10): 1131–1141. https://doi.org/10.1001/jamadermatol.2022.2909.
Review
For citations:
Kuptsova D.G., Petrichuk S.V., Murashkin N.N., Radigina T.V., Kurbatova O.V. Early predictors of efficacy of biological therapy for psoriasis in children. Allergology and Immunology in Paediatrics. 2023;(1):49-52. (In Russ.) https://doi.org/10.53529/2500-1175-2023-1-49-52
Views:
242
Email this article 